Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news

Show

From To
Over 10% in Older HIV Group Fit Alzheimer's Biomarker Risk Profile

Slightly more than 10% of older Australian patients with well-controlled HIV infection had cerebrospinal fluid (CSF) marker profiles consistent with Alzheimer's disease--a risk prevalence more than 10 times higher than in the general population at the same age.

Published
13 March 2013
From
NATAP
Long-term efavirenz linked to worse neurocognitive function in US CHARTER group

Long-term treatment with an efavirenz-based regimen correlated with worse neurocognitive function than did treatment with lopinavir/ritonavir, according to results of a retrospective case-control comparison within the US CHARTER cohort.

Published
07 March 2013
From
EATG / NATAP
Young Males With HIV Face Greater Risk of Hearing Loss

HIV infection is significantly associated with an increased risk of developing sudden sensorineural hearing loss (SSHL), according to research published online Feb. 21 in JAMA Otolaryngology-Head & Neck Surgery.

Published
02 March 2013
From
Journal of the American Academy of Physician Assistants
HIV Linked to Sudden Loss of Hearing

Having HIV appears to increase the risk of sudden sensorineural hearing loss, at least among younger patients, researchers reported.

Published
22 February 2013
From
MedPage Today HIV/AIDS
A 'neurosteroid' found to prevent brain injury caused by HIV/AIDS

A report in the The FASEB Journal describes how a network of steroid molecules in the brain, termed "neurosteroids," is disrupted during HIV infection leading to brain damage.

Published
31 January 2013
From
Eurekalert Inf Dis
Neuropathy and HIV: A Progress Report

Neuropathy affects up to 40% of all people with HIV, yet the treatment has remained more or less the same for decades. Prescribing drugs meant for other diseases, has led to haphazard results; time for a change - but is it happening?

Published
11 January 2013
From
PositiveLite
Neurocognitive impairment results in poorer adherence to HIV therapy

Neurocognitive impairment and problems with memory are associated with poorer adherence to antiretroviral therapy, investigators from the United States report in the online edition of the Journal

Published
07 January 2013
By
Michael Carter
HIV and hepatitis C co-infection increases the risk of cognitive impairment

Co-infection with HIV and hepatitis C is associated with an increased risk of cognitive impairment, according to research published in the online edition of the Journal of

Published
11 December 2012
By
Michael Carter
HIV-positive MSM have neurologic disease earlier than HIV-negatives

HIV-positive men who have sex with men (MSM) on antiretroviral therapy (ART) had neurologic disease at a younger age than HIV-negative MSM at risk for HIV infection in the US Multicenter AIDS Cohort Study (MACS). Compared with the HIV-negative group, HIV-positive men had significantly higher rates of four types of neurologic disease, including dementia.

Published
20 November 2012
From
International AIDS Society
Is protease inhibitor monotherapy sufficient to keep HIV under control in the brain?

Researchers in Sweden and Switzerland have been conducting clinical trials of PI monotherapy and HIV-related neurological research. Recently, two teams have separately reported that their data strongly suggest that injury to cells within the brain has occurred in some participants when exposed to PI monotherapy. The Swedish team recommends that PI monotherapy be used cautiously until further clinical trials are completed and more detailed information on the brain health of participants becomes available.

Published
02 November 2012
From
CATIE
← First12345...9Next →

Filter by country